Back to search
Anticoagulant-induced Bleeding
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant-induced Bleeding trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anticoagulant-induced Bleeding trials you may qualify forPANTHER-GI Pilot Study will assess the feasibility of a full-scale multicentre cohort management study evaluating the safety of a standardized strategy for resu…
The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE),…
The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb j…
There's no unified recommendation in clinical practice regarding adjusting dosages for different patient types, especially when adverse events occur. While riva…
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are recommended for stroke prevention in non-valvular atrial fibrillation (AF). Although NOACs s…
Aspirin and low molecular weight heparin (LMWH) are both commonly employed pharmacologic methods of venous thromboembolism (VTE) prophylaxis after orthopaedic s…